CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population.

BACKGROUND: The association between the human cytotoxic T lymphocyte-associated antigen-4 (CTLA4) gene and insulin-dependent diabetes mellitus (IDDM) is unclear in populations. We therefore investigated whether the gene conferred susceptibility to IDDM in a Russian population. We studied two polymorphic regions of the CTLA4 gene, the codon 17 dimorphism and the (AT)n microsatellite marker in the 3' untranslated region in 56 discordant sibling pairs and in 33 identical by descent (IBD) affected sibships.
RESULTS: The Alal7 allele of the CTLA4 gene was preferentially transmitted from parents to diabetic offspring (p<0.0001) as shown by the combined transmission/disequlibrium test (TDT) and sib TDT (S-TDT) analysis. A significant difference between diabetic and non-diabetic offspring was also observed for the transmission of alleles 17, 20, and 26 of the dinucleotide microsatellite. Allele 17 was transmitted significantly more frequently to affected offspring than to other children (p=0.0112) whereas alleles 20 and 26 were transmitted preferentially to non-diabetic sibs (p=0.045 and 0.00068 respectively). A nonrandom excess of the Ala17 CTLA4 molecular variant (maximum logarithm of odds score (MLS) of 3.26) and allele 17 of the dinucleotide marker (MLS=3.14) was observed in IBD-affected sibling pairs.
CONCLUSION: The CTLA4 gene is strongly associated with, and linked to IDDM in a Russian population.

Introduction

The cytotoxic T lymphocyte-associated antigen 4 gene (CTLA4) encodes the T cell receptor involved in the control of T cell proliferation and mediates T cell apoptosis [1]. The receptor protein is a specific T lymphocyte surface antigen that is detected on cells only after antigen presentation. Thus, CTLA4 is directly involved in both immune and autoimmune responses and may be involved in the pathogenesis of multiple T cell-mediated autoimmune disorders.

The human CTLA4 gene was mapped to chromosome 2q33 [2]. It consists of three exons. The first encodes a V-like domain of 116 amino acids. An A-to-G substitution at nucleotide 49 in exon 1 results in an amino acid substitution (Thr/Ala) in the leader peptide of the protein [3]. The Ala allele has been shown to predispose the individual carrying it to the development of various immune diseases including Graves' disease [3,4], Hashimoto's thyroiditis [5], Addison's disease [5], rheumatoid arthritis [6,7], celiac disease [8,9], and others [10].

The Thr17Ala dimorphism and the polymorphic (AT)n microsatellite starting at position 642 of the 3' untranslated region flanking exon 4 of the CTLA4 gene and located 5.3 kb 3' of the biallelic codon 17 were shown to be linked to, and associated with, insulin-dependent diabetes mellitus (IDDM) in Italian diabetic families [11]. This led Nistico et al. [11] to refer to the susceptibility to diabetes associated with CTLA4 as IDDM12. Further evidence for an IDDM susceptibility locus on chromosome 2 in 2q33, the region containing the CTLA4 gene, has been provided from various ethnic groups including Caucasians (British, Spanish, French, Swedish, and Belgian), Mexican-Americans, and Asians (Korean, Chinese, Japanese) [3,12-17]. In contrast, a lack of association of the CTLA4 gene with IDDM was observed in other Caucasian populations including Sardinians [12], Germans [18], Danish [19], and U.S. whites [20].

We therefore decided to investigate whether this gene conferred susceptibility to IDDM in a Russian population. We carried out family studies using two polymorphic markers at the CTLA4 gene locus: codon 17 dimorphism and the dinucleotide microsatellite in the 3' untranslated region.

Results

We observed preferential transmission of the Ala allele of the CTLA4 gene from parents to diabetic offspring (Table 1). The observed difference in transmission was highly significant, as shown by the transmission disequilibrium test (TDT) and combined TDT and sib TDT (S-TDT) analysis (p < 0.0001).

Table 1

Transmission of alleles of the codon 17 dimorphism at the CTLA4 locus from heterozygous parents to affected probands in 56 discordant sibling pairs with IDDM

Allele	TDT				Combined (TDT + S-TDT)
	Transmitted	Not transmitted	χ2a (df = 1)	P value	z'	P Value
Ala	39	11	15.680	0.00008	4.072	0.00003
Thr	11	39	15.680	0.00008	4.072	0.00003

For another polymorphic marker of the CTLA4 gene, the dinucleotide microsatellite, we detected 17 alleles from 92 to 130 bp in length. Alleles were designated according to the number of repeat units. For instance, the smallest allele contained 11 AT repeats and was referred to as allele 11. A significant difference between diabetic and non-diabetic offspring was observed for the transmission of three alleles numbers 17, 20, and 26, in combined TDT and S-TDT analysis (Table 2). Allele 17 was transmitted significantly more frequently to affected than to unaffected sibs (P = 0.0112) whereas alleles 20 and 26 were preferentially transmitted to non-diabetic sibs (P = 0.045 and 0.00068).

Table 2

Transmission of alleles of the (AT)n polymorphic marker at the CTLA4 locus from heterozygous parents to affected probands in 56 discordant sibling pairs with IDDM

Allele	TDT				Combined (TDT + S-TDT)
length, bp	Transmitted	Not transmitted	χ2a	P value	z'a	P value
11	0	2
12	1	1
13	4	9
14	1	0
15	9	5
16	14	9
17	21	4	11.560	0.0112	3.200	0.00112
18	7	2
19	1	2
20	2	14	9.000	0.0405	2.750	0.045
21	12	4
24	9	10
25	2	1
26	2	21	15.696	0.0017	3.956	0.00068
27	0	1
29	1	1
30	1	1

a Only χ2 (df = 1) and z' values for which P < 0.05 are indicated

We assessed the linkage to IDDM of both polymorphic markers of the CTLA4 gene in affected sibling pairs (ASPs), identical by descent (IBD), by assessing the significance of the deviation of the observed IBD allele distribution from a random distribution (Table 3). A nonrandom excess of the Ala17 allele was observed in IDDM ASPs (χ2 = 24.892, df = 1, p = 0.000015), with a logarithm of odds (LOD) score of 3.54. After correction for the number of alleles at this marker (2), our maximum LOD score (MLS) was reduced to 3.24 (Table 3). For the dinucleotide microsatellite, a MLS of 4.37 was obtained for the allele 17. Correction for the number of observed alleles (17) decreased the value to 3.17. Allele 17 displayed a distribution in APSs differed significantly from a random distribution (χ2 = 64.884, df = 2, p < 0.000001).

Table 3

CTLA4 allele sharing in IDDM ASPs

Marker	ASP (n)	Allele shared (%)			χ2 (df = 1)	P	MLSa
		2	1	0
Ala17 allele	30	17 (57)	11 (36)	2 (7)	24.892	0.000015	3.24
Allele 17	14	11 (79)	3 (21)	0	64.884	<0.000001	3.17

a The MLS value is corrected for the number of alleles observed for the polymorphic marker

Discussion and conclusion

TDT and S-TDT analyses revealed that both markers within the CTLA4 gene were significantly associated with IDDM in a Russian population. Both TDT and combined tests showed a clear association of the Thr17Ala dimorphism in the gene (Table 1). For the second polymorphic marker tested, the dinucleotide microsatellite, a significant difference in the transmission of the three alleles was observed, even after correction for multiple alleles (Table 2). This suggests that the (AT)n repeat polymorphism of the CTLA4 gene is associated with IDDM in this Russian population.

Transmission disequilibrium analysis in discordant sibling pairs showed that the Ala17 variant of the CTLA4 gene and allele 17 at the intragenic dinucleotide microsatellite were associated with a high risk of IDDM. The maximum LOD scores were also sufficient to indicate that the CTLA-4 region of chromosome 2q33 is linked to, and associated with, IDDM in a Russian population.

Thus, our findings are consistent with those of earlier family studies showing a positive association between the CTLA4 gene and IDDM in most populations tested and role of the Ala17 allele is predisposing the individual to the disorder [3,11-17]. Linkage analysis with a CTLA4 dinucleotide marker in 48 Italian IDDM families gave a ML of 3.22 which is consistent with our results [11]. Our findings suggest that allele 17 is a common 'predisposition' allele of the dinucleotide marker. Our data are consistent with those of Marron et al. [12] who reported a significantly higher frequency of allele 17 to affected siblings in pooled diabetic pedigrees from multiple ethnic groups than of other alleles of the dinucleotide marker. Allele 17 was in strong linkage disequilibrium with the Ala allele in the Russian population and in other populations tested (data not shown) [12].

The CTLA4 gene (IDDM12) is located in the vicinity of two other IDDM susceptibility regions, IDDM7 (2q31) [21] and IDDM13 (2q34) [22], and the genes encoding CD28, IA-2 and islet tyrosine phosphatase, which may be considered to be candidate IDDM susceptibility genes [23]. This closeness to other IDDM susceptibility regions and putative susceptibility genes may account for the weakness or absence of association of the CTLA4 gene with IDDM in some populations.

A functional significance of the CTLA4 codon 17 dimorphism is unknown. The amino acid substitution thought unlikely to affect the function of the CTLA-4 molecule. The CTLA4 microsatellite (AT)n repeat may affect RNA stability, for the AT-rich sequences in 3' untranslated regions of mRNA molecules for example [24,25]. Linkage between the two CTLA4 polymorphic markers has been shown [26]. This may indirectly affect CTLA4 signal transduction or intracellular sorting [27]. The Ala17 allele is probably correlated with rapid-onset insulin deficiency, and functional studies with Ala/Ala homozygous patients may elucidate the functional significance of codon 17 dimorphism in T-cell regulation [28].

CTLA4 is known to be involved in the fine tuning of the immune response, the disruption of which may result in autoimmunity. Recent animal model-based studies have shown that CTLA4Ig injection can prevent relapse of the autoimmune process in BB rats [28]. This suggests that CTLA4 may be a suitable target for the specific prevention of β-cell autoimmunity [27].

Our data, showing the linkage and association of the CTLA4 gene with IDDM, together with many other population-based fundings, suggest that the chromosome 2q33 region (IDDM12) is a true IDDM susceptibility locus. The CTLA4 region may function as a common locus for HLA.genes and genes conferring susceptibility to autoimmunity in general. A number of findings, including our studies of association between CTLA4 codon 17 and Graves' disease [29], support this view.

Materials and methods

Subjects

Fifty-six Russian families, each consisting of two siblings (one affected with IDDM diagnosed before the age of 18 years and one non-diabetic sibling) were studied. Sixteen families were recruited from The Samara Diabetic Center, the other families being recruited from the Endocrinological Research Center in Moscow. Thirty-three nuclear diabetic families, recruited from the Endocrinological Research Center and consisting of two unaffected parents and two sibs with IDDM, were also analysed.

DNA typing

Human DNA was extracted from whole blood using a phenol-chloroform technique [30]. A polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay was used to detect Thr17Ala dimorphism as described by Donner et al. [3]. The dinucleotide repeat polymorphism was studied by PCR, as described by Polymeropoulos et al. [31]. DNA fragments were separated by electrophoresis in 12% polyacrylamide gels and stained with silver nitrate [32].

Statistical analysis

We carried out linkage disequilibrium analysis in discordant sibling pairs by combined TDT and S-TDT analysis [33,34]. For TDT, we estimated the significance of deviations from a random pattern of allele transmission was estimated using the χ2 test. For both S-TDT and the combined test, a z score was calculated for each allele. A nominal P value of less than 0.05 after correction for multiple alleles was considered significant.

Linkage between polymorphic markers and susceptibility to IDDM was assessed in APSs by assessment of the extent to which the observed distribution of shared alleles, identical by descent, differed from a random distribution (1:2:1 for sharing of 2, 1, and 0 alleles would be expected). Parents homozygous for an allele were considered to be genetically uninformative. χ2 was calculated using Roff & Bentzen's algorithm [35] to determine the significance of the degree of excess allele sharing by ASPs. The logarithm of odds score was calculated as described by Risch [36] using correction for the number of alleles tested [37]. A LOD score of 3.0 or more was considered to indicate significant linkage.